CAM
VRTX icon

Costello Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Costello Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$263K Sell
589
-12
-2% -$5.6K 0.09% 95
2025
Q4 		$272K Buy
601
+12
+2% +$5.17K 0.09% 94
2025
Q3 		$231K Sell
589
-100
-15% -$41.8K 0.08% 101
2025
Q2 		$307K Buy
689
+24
+4% +$11.1K 0.12% 87
2025
Q1 		$322K Buy
+665
New +$310K 0.13% 78

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Costello Asset Management's VRTX Position: Q1 2026 in Review

Costello Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 2% in Q1 2026, selling an estimated $5.6K and leaving 589 shares worth $263K. The position accounts for 0.09% of the portfolio, ranked #95.

Costello Asset Management first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $322K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Costello Asset Management held 589 shares of Vertex Pharmaceuticals worth $263K as of Q1 2026.
  • Costello Asset Management sold 12 Vertex Pharmaceuticals shares in Q1 2026, an estimated $5.6K.
  • Vertex Pharmaceuticals made up 0.09% of Costello Asset Management's portfolio in Q1 2026, its #95 holding.
  • Costello Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Costello Asset Management's Vertex Pharmaceuticals position peaked at $322K in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Costello Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.